Update on Solid Ignite DMDOctober 2, 2020 5:34 pm
We are absolutely delighted to hear the news that the FDA has lifted the SOLID IGNITE DMD Phase 1/11 Gene Therapy Clinical Trial which had been put on hold due to a serious adverse event with a child taking part in the trial.
Gene therapies use engineered viruses to carry healthy genetic material into a person’s cells to replace faulty or mutated genes that cause a disease or condition.
Alex’s Wish funded £50K towards this clinical trial. We wish SOLID all the very best with the next steps and hope this results in effective treatments in the future.
Posted in Uncategorized